about
Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma PatientsNon-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas.Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization.A mathematical model describes the malignant transformation of low grade gliomas: Prognostic implications.Glucose-lactate metabolic cooperation in cancer: insights from a spatial mathematical model and implications for targeted therapy.A mathematical model for the glucose-lactate metabolism of in vitro cancer cells.Hypoxic cell waves around necrotic cores in glioblastoma: a biomathematical model and its therapeutic implications.Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival.Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events.Influence of gray level and space discretization on brain tumor heterogeneity measures obtained from magnetic resonance images.Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.Delay effects in the response of low-grade gliomas to radiotherapy: a mathematical model and its therapeutical implications.Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline 18F-FDG PET/CT in breast cancer with neoadjuvant chemotherapy indication.Metabolic Tumor Burden Assessed by Dual Time Point [18F]FDG PET/CT in Locally Advanced Breast Cancer: Relation with Tumor Biology.Combined therapies of antithrombotics and antioxidants delay in silico brain tumour progression.Morphological MRI-based features provide pretreatment survival prediction in glioblastomaRegulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomideIntratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogateCorrection to: Morphological MRI-based features provide pretreatment survival prediction in glioblastomaA three-dimensional computational analysis of magnetic resonance images characterizes the biological aggressiveness in malignant brain tumours
P50
Q36111620-0C1A0B4B-1A0C-4D3A-B614-C0F0188E839BQ36389363-099C08EC-93A5-4661-8983-327A03D0E809Q36393965-36621461-C078-4DF7-A65F-3C428477F783Q38649268-F778E3D3-F390-42C3-BDFA-7FCFF2E599CAQ38952460-19E020F2-6536-43A0-868F-0AB97EF731FAQ39424237-ACE64B29-7002-4766-B0A4-E367C21C6245Q41883885-0B5E4997-E1B5-4D40-8597-7857A7E12EC9Q42019179-4018DCA7-E79F-40D8-BCBF-8453F332FD5AQ47140400-1938A1D4-74CE-403D-AAD3-A8C3660DEC2AQ48003634-5946DA31-F1BD-4D79-8191-7921F12933E8Q48464456-F6EB01FD-27BA-470E-90EA-C9427313AE74Q48663115-DC94A65A-D731-422B-8FBB-8683C459F15CQ48769187-0F13E182-2815-4854-8506-8A9D6A3AAF1DQ50161510-E9E6E27E-0BE4-45FD-BEBD-CB3E32D37A67Q51008272-809C6AC1-4AA8-4C8B-BBA6-EE067DBA589CQ51109324-1B73D9E8-10C5-4832-AA45-19C295628BF9Q57462580-D92C536A-E83A-42AA-877C-585D57525FF6Q67228105-95997463-642D-4168-A79C-5DF813145674Q88993324-17FF2A81-5498-4A9A-A1CF-832BADAB535DQ90469835-8618603B-B16E-460D-845C-4231F969FBDBQ92924304-645494CF-26AC-44EA-A460-7B81A9AE37BA
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Alicia Martínez-González
@en
Alicia Martínez-González
@nl
type
label
Alicia Martínez-González
@en
Alicia Martínez-González
@nl
prefLabel
Alicia Martínez-González
@en
Alicia Martínez-González
@nl
P31
P496
0000-0002-6938-0932